The trading week might be coming to a close, but investors are going to continue to hunt for new stocks to track. Yesterday, the CBD Life Sciences Inc. (OTC:CBDL) stock had come into focus, and it could be the one to track this morning.
Regulatory Optimism
In a news release yesterday, CBD Life Sciences stated that the marijuana market in the United States was on the verge of explosive growth owing to recent moves taken towards federal legalization of the product by the Joe Biden administration.
The company noted that the situation was a massive new opportunity that would enable it to cash in on an opportunity that would come along once in a generation. That would lay the foundations of the company’s journey into becoming a major force in the hemp industry.
Strong Potential Growth
The legal cannabis market in the United States is projected to surpass a valuation of $70 billion by 2028, as per industry estimates. The growth would be brought about by a considerable rise in demand for both medicinal and recreational products.
Such a state of affairs would not only lead to significant new sources of new revenues for marijuana firms but also CBD-focused businesses. CBD Life Sciences already boasts of a wide range of innovative products and partnerships at the retail level, which is why the company could be in a strong position for the impending growth.
 Stock Continues To Trend Higher){kind=link}